Dave Humphrey
2022 - Ensysce Biosciences
In 2022, Dave Humphrey earned a total compensation of $780.6K as Chief Financial Officer at Ensysce Biosciences.
Compensation breakdown
| Option Awards | $438,562 |
|---|---|
| Salary | $328,333 |
| Other | $13,722 |
| Total | $780,617 |
Humphrey received $438.6K in option awards, accounting for 56% of the total pay in 2022.
Humphrey also received $328.3K in salary and $13.7K in other compensation.
Rankings
In 2022, Dave Humphrey's compensation ranked 3,546th out of 5,736 executives tracked by ExecPay. In other words, Humphrey earned more than 38.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,546 out of 5,736 | 38th |
Division Manufacturing | 2,017 out of 3,125 | 36th |
Major group Chemicals And Allied Products | 964 out of 1,416 | 32nd |
Industry group Drugs | 902 out of 1,317 | 32nd |
Industry Pharmaceutical Preparations | 657 out of 963 | 32nd |
Source: SEC filing on October 17, 2024.
Humphrey's colleagues
We found three more compensation records of executives who worked with Dave Humphrey at Ensysce Biosciences in 2022.